The Aptamers Market accounted to USD XX.XX million in 2017 growing at a CAGR of XX.XX% during the forecast period of 2018 to 2025. Aptamers market report contains data for historic years 2016, the base year of calculation is 2017 and the Aptamers forecast period is 2018 to 2025 (Current Year Statistic Will Be Provided in Report).
Get Sample Research Report: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-aptamers-market
There are many advantages of these small molecules in comparison to the antibodies. The aptamers market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. Some of the major players operating in aptamers market are
- Aptamer Sciences, Inc.
- Aptagen, LLC.
- Aptamer Group
- Aptus Biotech
- Base Pair Biotechnologies
- NeoVentures Biotechnology Inc.
- SOMALOGIC, INC.
- TriLink BioTechnologies, LLC
- Vivonics Inc.
- NOXXON Pharma
Others: Ophthotech Corporation, 2bind, NOVAPTECH, Donovan, LLC, ATDBio Ltd., AuramerBio, Barrick Lab, Creative Biogene, AMS Biotechnology (Europe) Limited, IBA GmbH and Kaneka Corporation among others.
Aptamers are single-stranded DNA or RNA (ssDNA or ssRNA) molecules. Aptamers are the oligonucleotide or peptide molecules that bind to a specific target molecule. It assumes to have variety of shapes due to their tendency to form helices and single-stranded loops.
Get TOC of Full Report: https://databridgemarketresearch.com/toc/?dbmr=global-aptamers-market
Major Market Drivers and Restraints:
- Increased R&D investments in biotechnology and pharmaceutical sectors
- Low cost of aptamers
- High efficiency of aptamers to bind large molecules as compared to antibodies
- Technological advancements
- Patent Expiration of SELEX
- Low market acceptance
- Lack of trained professionals
Market Segmentation: Global Aptamers Market
- The global aptamers market is segmented by type into DNA-based aptamers, RNA-based aptamers and XNA-based aptamers.
- On the basis of application the market is segmented into diagnostics, therapeutics development, research and development (R&D) and others.
- On the basis of technology the market is segmented into systemic evolution of ligands by exponential enrichment (SELEX) and others.
- By End User the market is segmented into academic and government research institutes, biotechnology & pharmaceutical companies and contract research organizations.
- On the basis of geography, aptamers market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa.
- Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.
Want Full Report? Enquire Here: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-aptamers-market
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get 10% Discount on Report by emailing email@example.com . We are content with our glorious 99.9 % client satisfying rate.